PRCTPROCEPT BioRobotics Corp

Nasdaq procept-biorobotics.com


$ 60.31 $ -2.43 (-3.87 %)    

Wednesday, 08-May-2024 15:59:54 EDT
QQQ $ 440.60 $ 0.14 (0.03 %)
DIA $ 390.50 $ 1.74 (0.45 %)
SPY $ 517.10 $ 0.05 (0.01 %)
TLT $ 90.04 $ 0.00 (0 %)
GLD $ 214.13 $ -0.57 (-0.27 %)
$ 60.36
$ 62.60
$ 0.00 x 0
$ 0.00 x 0
$ 60.14 - $ 63.76
$ 24.83 - $ 65.00
602,745
na
3.08B
$ 1.64
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-02-2024 03-31-2024 10-Q
2 02-28-2024 12-31-2023 10-K
3 11-02-2023 09-30-2023 10-Q
4 07-28-2023 06-30-2023 10-Q
5 05-04-2023 03-31-2023 10-Q
6 02-28-2023 12-31-2022 10-K
7 11-04-2022 09-30-2022 10-Q
8 08-05-2022 06-30-2022 10-Q
9 05-06-2022 03-31-2022 10-Q
10 03-22-2022 12-31-2021 10-K
11 11-05-2021 09-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 td-cowen-maintains-buy-on-procept-biorobotics-raises-price-target-to-75

TD Cowen analyst Joshua Jennings maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Buy and raises the price target from $65...

 piper-sandler-maintains-overweight-on-procept-biorobotics-raises-price-target-to-75

Piper Sandler analyst Matt O'Brien maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Overweight and raises the price ta...

 procept-biorobotics-announces-real-world-long-term-data-demonstrate-sustained-benefits-of-aquablation-therapy-for-men-with-benign-prostatic-hyperplasia

PROCEPT BioRobotics® Corporation (NASDAQ:PRCT) (the "Company"), a surgical robotics company focused on advancing patien...

 truist-securities-maintains-buy-on-procept-biorobotics-raises-price-target-to-72

Truist Securities analyst Richard Newitter maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Buy and raises the price targe...

 procept-biorobotics-q1-2024-gaap-eps-051-beats-055-estimate-sales-44539m-beat-41577m-estimate

PROCEPT BioRobotics (NASDAQ:PRCT) reported quarterly losses of $(0.51) per share which beat the analyst consensus estimate of $...

 truist-securities-maintains-buy-on-procept-biorobotics-raises-price-target-to-58

Truist Securities analyst Richard Newitter maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Buy and raises the price targe...

 procept-biorobotics-projects-full-year-2024-revenue-to-be-approximately-210m-est-204458m

The Company projects full year 2024 gross margin to be approximately 57% to 59%, and Adjusted EBITDA loss to be approximately $...

 procept-biorobotics-q4-2023-gaap-eps-054-misses-044-estimate-sales-4358m-beat-4206m-estimate

PROCEPT BioRobotics (NASDAQ:PRCT) reported quarterly losses of $(0.54) per share which missed the analyst consensus estimate of...

 earnings-scheduled-for-february-27-2024

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on rev...

 procept-biorobotics-shares-are-higher-today-ceo-touts-strong-surgeon-interest

Procept BioRobotics Corp (NASDAQ: PRCT) shares are trading higher after the company announced fourth-quarter (Q4) FY23 

 wells-fargo-maintains-overweight-on-procept-biorobotics-raises-price-target-to-47

Wells Fargo analyst Nathan Treybeck maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Overweight and raises the price targe...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION